Peter Luo bought $85k of ADAG
Chief Executive Officer at Adagene Inc.. 23,245 shares at an average of $3.65, traded Aug 4, 2026, filed Aug 6, 2026.
Score components
- +25RoleCEO
- +9Trade size$85k at market
- +10Relative to holdingsHoldings up 52%
- +4Price context24% below the 52-week high
- +8Cluster2 insiders buying within 14 days
- 0Repeat buyingFirst buy in 90 days
- 0Track recordToo few past buys to judge (0 with prices)
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001104659-26-092176, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Aug 4, 2026 | POpen-market purchase American Depositary Shares (ADS) | +22,966 | $3.65 | $84k | 67,966 | Aug 6, 2026 |
| Aug 5, 2026 | POpen-market purchase American Depositary Shares (ADS) | +279 | $3.65 | $1,018 | 68,245 | Aug 6, 2026 |
Related signals
Other insiders at Adagene Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 36Weak | Adagene Inc. | Man Kin Tam Chief Financial Officer | $6,000 2,000 shares | +20% | |
| 47Moderate | Adagene Inc. | Peter Luo Chief Executive Officer | $64k 20,290 shares | +30% | |
| 35Weak | Adagene Inc. | Cuong Do V director | $7,500 2,000 shares | - |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.